Compare STRO & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STRO | WHF |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | 131 | 3 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.9M | 157.2M |
| IPO Year | N/A | N/A |
| Metric | STRO | WHF |
|---|---|---|
| Price | $24.10 | $7.31 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 8 | 2 |
| Target Price | ★ $26.38 | $7.75 |
| AVG Volume (30 Days) | ★ 173.7K | 124.3K |
| Earning Date | 03-23-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 14.50% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.45 | N/A |
| P/E Ratio | ★ N/A | $15.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $6.07 |
| 52 Week High | $27.96 | $9.95 |
| Indicator | STRO | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 60.10 | 57.92 |
| Support Level | $0.76 | $6.80 |
| Resistance Level | $27.96 | $7.51 |
| Average True Range (ATR) | 2.17 | 0.20 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 67.50 | 63.16 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.